Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Course Antimicrobial Therapy for Sepsis
NCT02899143Phase 2Unknown
- Sponsor
- Ospedale Santa Maria delle Croci
- Start
- Sep 2016
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 2, randomised trial in sepsis (2 arms), sponsored by Ospedale Santa Maria delle Croci. Primary endpoint: Sepsis-related organ dysfunction at 14 days. Status: unknown.
02
Conditions
sepsis
Beyond the preview
Go deeper on NCT02899143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02899143.